Edoxaban, an oral direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro

被引：0
|
作者：
Morishima, Y. [1 ]
Honda, Y. [1 ]
Kamisato, C. [1 ]
机构：
[1] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：688 / 688
页数：1
相关论文
共 50 条
  • [41] Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
    Hillarp, Andreas
    Strandberg, Karin
    Baghaei, Fariba
    Blixter, Inger Fagerberg
    Gustafsson, Kerstin M.
    Lindahl, Tomas L.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (7-8): : 575 - 583
  • [42] Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
    Perzborn, E.
    Heitmeier, S.
    Buetehorn, U.
    Laux, V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) : 1054 - 1065
  • [43] Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis
    Porres-Aguilar, Mateo
    Najera, Carolina
    Mares, Adriana C.
    Benzidia, Ilham
    Prakash, Swathi
    Crichi, Benjamin
    ANGIOLOGY, 2023,
  • [44] EFFECT OF NAPROXEN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN, AN ORAL FACTOR Xa INHIBITOR.
    Mendell-Harary, J.
    Chen, S.
    Noveck, R. J.
    Lee, F.
    Petrushun, V.
    Shi, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S63 - S63
  • [45] Pharmacokinetics of the Direct Factor Xa Inhibitor Edoxaban and Digoxin Administered Alone and in Combination
    Mendell, Jeanne
    Noveck, Robert J.
    Shi, Minggao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (04) : 335 - 341
  • [46] Effects of novel factor Xa inhibitor YM150 on in vitro human platelet activation and aggregation
    Kaku, S.
    Suzuki, K.
    Sasamata, M.
    Miyata, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 995 - 995
  • [47] Incongruous inhibition of human factor Xa and tissue factor by porcine tissue factor inhibitor.
    Kopp, CW
    Bach, FH
    Geczy, C
    Robson, SC
    HEPATOLOGY, 1996, 23 (01) : T32 - T32
  • [48] Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates
    Fukuda, Toshio
    Tsuji, Naoki
    Honda, Yuko
    Kamisato, Chikako
    Morishima, Yoshiyuki
    Shibano, Toshiro
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 1062 - 1068
  • [49] Rivaroxaban An Oral Direct Factor Xa Inhibitor for the Prevention of Thromboembolism
    Chen, Terry
    Lam, Sum
    CARDIOLOGY IN REVIEW, 2009, 17 (04) : 192 - 197
  • [50] Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats
    Morishima, Yoshiyuki
    Honda, Yuko
    Kamisato, Chikako
    Tsuji, Naoki
    Kita, Akemi
    Edo, Naoko
    Shibano, Toshiro
    THROMBOSIS RESEARCH, 2012, 130 (03) : 514 - 519
12345